My Healthy Waist

In the Spotlight

The value of time: The more you move, the lower your risk to develop type 2 diabetes

The wide benefits of being regularly engaged in physical activity to prevent or delay cardiometabolic diseases have been known for decades. However, accurately measuring physical activity in epidemiological research has been challenging as it primarily relied on self-report questionnaires, the limitations of which have been documented in several studies. Indeed, self-report questionnaires often lead to … Continued

Could you discuss the issue of beverages in diet?

Expert opinion by Benoît Lamarche, PhD, FAHA, Professor, Institute of Nutraceuticals and Functional Foods, Université Laval, Québec, QC, Canada

Slide Library: Global Sugar-Sweetened Beverage Sale Barometer

The European Healthy Lifestyle Alliance (EHLA) and Benoit Arsenault, PhD, Professor, Faculty of Medicine, Université Laval, Centre de recherche de l’IUCPQ, Québec, QC, Canada

Webcast: Ectopic fat and cardiometabolic health: an update

This video presents a discussion on ectopic fat depots by three experts in this area, Dr. Ulf Smith from Sweden, Dr. Marja-Riitta Taskinen from Finland and Dr. Michael Jensen from United States. Dr. Smith introduces the notion of ectopic fat by raising the issue that BMI is not the best measurement to assess individual risk … Continued

Latest News

Associations of changes in physical activity and sedentary time with weight recurrence after bariatric surgery: a 5-year prospective study.

Int J Obes (Lond). 2023;47:463-470
Sundgot-Borgen C, Bond DS, Sniehotta FF, Kvalem IL, Hansen BH, Bergh I, Rø Ø, Mala T

Longitudinal metabolomics of increasing body-mass index and waist-hip ratio reveals two dynamic patterns of obesity pandemic.

Int J Obes (Lond). 2023;47:453-462
Mäkinen VP, Kettunen J, Lehtimäki T, Kähönen M, Viikari J, Perola M, Salomaa V, Järvelin MR, Raitakari OT, Ala-Korpela M

Nonnutritive sweeteners and glucose intolerance: Where do we go from here?

J Clin Invest. 2023;133:e171057
Nobs SP, Elinav E

Dose-response relationships between objectively measured daily steps and mortality among frail and nonfrail older adults.

Med Sci Sports Exerc. 2023;55:1044-1053
Watanabe D, Yoshida T, Watanabe Y, Yamada Y, Miyachi M, Kimura M

Recent Contributions

The value of time: The more you move, the lower your risk to develop type 2 diab ...

The wide benefits of being regularly engaged in physical activity to prevent or delay cardiometabolic diseases have been known for decades. However, accurately measuring physical activity in epidemiological research has been challenging as it primarily relied on self-report questionnaires, the limitations of which have been documented in several studies. Indeed, self-report questionnaires often lead to … Continued

Visceral adiposity: a key driver of non-alcoholic fatty liver disease

Liver fat accumulation/non-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition and has become a major cause of liver failure. Imaging studies have shown that excess liver fat is frequently accompanied by an excess of abdominal visceral adipose tissue. Excess visceral adiposity is associated with an increased risk of type 2 diabetes and cardiovascular … Continued

Eat well and move: another success story!

Being physically active and having a high-quality dietary pattern are two key features of our lifestyle associated with a healthier cardiometabolic risk profile, contributing to longer and healthier lives. However, beyond their individual influence on cardiometabolic risk, what about the mortality risk associated with these two important markers of our lifestyle when they are simultaneously … Continued

NAFLD and cardiometabolic outcomes: contribution of excess visceral adiposity

Many studies worldwide have reported a close relationship between a high-risk obesity pattern, visceral obesity, and an altered cardiometabolic risk profile beyond total adiposity. Moreover, excess visceral adiposity is a significant risk factor for both cardiovascular disease (CVD) and type 2 diabetes. Non-alcoholic fatty liver disease (NAFLD), another prevalent condition frequently observed among patients with … Continued

It is important SO MEASURE IT!

Calendar of Events

59th EASD Annual Meeting

Obesity Week 2023

Endobridge 2023